These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia. Marshall GA; Gatchel JR; Donovan NJ; Muniz MC; Schultz AP; Becker JA; Chhatwal JP; Hanseeuw BJ; Papp KV; Amariglio RE; Rentz DM; Sperling RA; Johnson KA J Alzheimers Dis; 2019; 67(2):757-768. PubMed ID: 30689584 [TBL] [Abstract][Full Text] [Related]
48. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease. Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330 [TBL] [Abstract][Full Text] [Related]
49. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377 [TBL] [Abstract][Full Text] [Related]
51. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting. Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225 [TBL] [Abstract][Full Text] [Related]
52. Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment. Kemppainen N; Joutsa J; Johansson J; Scheinin NM; Någren K; Rokka J; Parkkola R; Rinne JO J Alzheimers Dis; 2015; 48(1):123-33. PubMed ID: 26401934 [TBL] [Abstract][Full Text] [Related]
53. Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer's disease in mild cognitive impairment patients. Ciarmiello A; Tartaglione A; Giovannini E; Riondato M; Giovacchini G; Ferrando O; De Biasi M; Passera C; Carabelli E; Mannironi A; Foppiano F; Alfano B; Mansi L Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):288-296. PubMed ID: 30244387 [TBL] [Abstract][Full Text] [Related]
54. Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation. Arenaza-Urquijo EM; Bejanin A; Gonneaud J; Wirth M; La Joie R; Mutlu J; Gaubert M; Landeau B; de la Sayette V; Eustache F; Chételat G Neurobiol Aging; 2017 Nov; 59():72-79. PubMed ID: 28764930 [TBL] [Abstract][Full Text] [Related]
55. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD). Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111 [TBL] [Abstract][Full Text] [Related]
56. Applying the ATN scheme in a memory clinic population: The ABIDE project. Altomare D; de Wilde A; Ossenkoppele R; Pelkmans W; Bouwman F; Groot C; van Maurik I; Zwan M; Yaqub M; Barkhof F; van Berckel BN; Teunissen CE; Frisoni GB; Scheltens P; van der Flier WM Neurology; 2019 Oct; 93(17):e1635-e1646. PubMed ID: 31597710 [TBL] [Abstract][Full Text] [Related]
57. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
58. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
60. Factors related to prevalence, persistence, and incidence of depressive symptoms in mild cognitive impairment: vascular depression construct. Kim S; Woo SY; Kang HS; Lim SW; Choi SH; Myung W; Jeong JH; Lee Y; Hong CH; Kim JH; Na H; Carroll BJ; Kim DK Int J Geriatr Psychiatry; 2016 Jul; 31(7):818-26. PubMed ID: 26679895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]